News

Pharmabiz7h
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
Pharmabiz7h
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Pharmabiz7h
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:30 Hrs [IST] The induction programme 2025 for new ...
Pharmabiz7h
Zydus Wellness posts net sales of Rs. 8,577 million in Q1FY26
Zydus Wellness posts net sales of Rs. 8,577 million in Q1FY26: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:15 Hrs [IST] Reporting its first quarter results for FY 26, Zydus We ...
Pharmabiz8h
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify: Our Bureau, Mumbai Wednesday, July 30, 2025, 16:50 Hrs [IST] Rockwell Automatio ...
Pharmabiz9h
Veranova appoints Thomas Rohrer as vice president of bioconjugation
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Pharmabiz9h
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
Pharmabiz10h
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Pharmabiz10h
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...
Pharmabiz11h
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Pharmabiz12h
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...
Pharmabiz13h
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...